DEVELOPMENT OF MITOCHONDRIAL-TARGETED DRUG DELIVERY SYSTEM

Mitochondria are organelles surrounded by a double membrane and are present in almost all eukaryotic cells and are described as producing energy sources in the cell. In addition, mitochondria have an important role in cell cycle regulation including cell growth, proliferation, differentiation and...

Full description

Saved in:
Bibliographic Details
Main Author: Novia Khaeranny, Ryan
Format: Theses
Language:Indonesia
Online Access:https://digilib.itb.ac.id/gdl/view/62900
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Institut Teknologi Bandung
Language: Indonesia
id id-itb.:62900
spelling id-itb.:629002022-01-21T10:32:02ZDEVELOPMENT OF MITOCHONDRIAL-TARGETED DRUG DELIVERY SYSTEM Novia Khaeranny, Ryan Indonesia Theses Mitochondria, Reactive Oxygen Species, Liposome, Dequalinium Chloride, Antioxidant, Quercetin INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/62900 Mitochondria are organelles surrounded by a double membrane and are present in almost all eukaryotic cells and are described as producing energy sources in the cell. In addition, mitochondria have an important role in cell cycle regulation including cell growth, proliferation, differentiation and cell death. Mitochondria dysfunction contributes widely to a number of disorders in the human body. Ranging from neurodegenerative, neuromuscular, obesity, diabetes to ischemia-reperfusion and cancer. In this study, a liposome-based mitochondrial-targeted nanocarrier system was developed with a composition of 1,2-dioleyl-sn-glycero-3-phosphoethanolamine (DOPE) as the main lipid and cholesterol as an auxiliary lipid, which was conjugated with a mitochondrial agent, namely dequalinium (DQA). The results of the size characterization of Liposom-DQA (LipoDQ) nanoparticles obtained from this study were 124.50 ± 4.95 nm with a polydispersity index of 0.25 ± 0.05. While the zeta potential measurement results obtained are +11.40 mV, this positive value indicates the successful incorporation of dequalinium into the liposome structure. This characterization was then confirmed by TEM measurements which showed a spherical shape of the particles with sizes below 200 nm. Observations on confocal microscopy on TM4 cells revealed the presence of LipoDQ localization in the mitochondria. This was confirmed by the presence of bright yellow fluorescence indicating the composition of red and green fluorescence, and indicating the co-localization of nanocarriers into mitochondria. Furthermore, the high value of Pearson's Coefficient LipoDQ (0.73 ± 0.05) indicated that most of the nanocarriers were localized in mitochondria. The results of the characterization of LipoDQ containing quercetin obtained a particle size of 147.90 ± 4.49 nm with a polydisperity index of 0.24 ± 0.58, a zeta potential value of + 5.35 ±1.26 mV and an entrapment efficiency of 32.84 ±10.55%. The antioxidant activity of quercetin which was incorporated into the LipoDQ nanocarrier system showed antioxidant activity that was not much different from the antioxidant activity of free quercetin where the inhibitory concentration (IC50) values produced were 2.95 ± 1.73 µM and 3.33 ± 0.43 µM, respectively. text
institution Institut Teknologi Bandung
building Institut Teknologi Bandung Library
continent Asia
country Indonesia
Indonesia
content_provider Institut Teknologi Bandung
collection Digital ITB
language Indonesia
description Mitochondria are organelles surrounded by a double membrane and are present in almost all eukaryotic cells and are described as producing energy sources in the cell. In addition, mitochondria have an important role in cell cycle regulation including cell growth, proliferation, differentiation and cell death. Mitochondria dysfunction contributes widely to a number of disorders in the human body. Ranging from neurodegenerative, neuromuscular, obesity, diabetes to ischemia-reperfusion and cancer. In this study, a liposome-based mitochondrial-targeted nanocarrier system was developed with a composition of 1,2-dioleyl-sn-glycero-3-phosphoethanolamine (DOPE) as the main lipid and cholesterol as an auxiliary lipid, which was conjugated with a mitochondrial agent, namely dequalinium (DQA). The results of the size characterization of Liposom-DQA (LipoDQ) nanoparticles obtained from this study were 124.50 ± 4.95 nm with a polydispersity index of 0.25 ± 0.05. While the zeta potential measurement results obtained are +11.40 mV, this positive value indicates the successful incorporation of dequalinium into the liposome structure. This characterization was then confirmed by TEM measurements which showed a spherical shape of the particles with sizes below 200 nm. Observations on confocal microscopy on TM4 cells revealed the presence of LipoDQ localization in the mitochondria. This was confirmed by the presence of bright yellow fluorescence indicating the composition of red and green fluorescence, and indicating the co-localization of nanocarriers into mitochondria. Furthermore, the high value of Pearson's Coefficient LipoDQ (0.73 ± 0.05) indicated that most of the nanocarriers were localized in mitochondria. The results of the characterization of LipoDQ containing quercetin obtained a particle size of 147.90 ± 4.49 nm with a polydisperity index of 0.24 ± 0.58, a zeta potential value of + 5.35 ±1.26 mV and an entrapment efficiency of 32.84 ±10.55%. The antioxidant activity of quercetin which was incorporated into the LipoDQ nanocarrier system showed antioxidant activity that was not much different from the antioxidant activity of free quercetin where the inhibitory concentration (IC50) values produced were 2.95 ± 1.73 µM and 3.33 ± 0.43 µM, respectively.
format Theses
author Novia Khaeranny, Ryan
spellingShingle Novia Khaeranny, Ryan
DEVELOPMENT OF MITOCHONDRIAL-TARGETED DRUG DELIVERY SYSTEM
author_facet Novia Khaeranny, Ryan
author_sort Novia Khaeranny, Ryan
title DEVELOPMENT OF MITOCHONDRIAL-TARGETED DRUG DELIVERY SYSTEM
title_short DEVELOPMENT OF MITOCHONDRIAL-TARGETED DRUG DELIVERY SYSTEM
title_full DEVELOPMENT OF MITOCHONDRIAL-TARGETED DRUG DELIVERY SYSTEM
title_fullStr DEVELOPMENT OF MITOCHONDRIAL-TARGETED DRUG DELIVERY SYSTEM
title_full_unstemmed DEVELOPMENT OF MITOCHONDRIAL-TARGETED DRUG DELIVERY SYSTEM
title_sort development of mitochondrial-targeted drug delivery system
url https://digilib.itb.ac.id/gdl/view/62900
_version_ 1822004201111158784